ROTUOC
PBYI icon

Regents of the University of California’s Puma Biotechnology PBYI Stock Holding History

Regents of the University of California’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,900
Closed -$2.1M – 61
2015
Q1 		$2.1M Buy
+8,900
New +$1.9M 2.12% 10

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Regents of the University of California's PBYI Position: Q2 2015 in Review

Regents of the University of California sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 8,900 shares — an estimated $2.1M sold.

Regents of the University of California first reported a position in PBYI in Q1 2015 and held it in 1 quarter. The position peaked at $2.1M in Q1 2015. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

  • Regents of the University of California reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
  • Regents of the University of California sold 8,900 Puma Biotechnology shares in Q2 2015, an estimated $2.1M.
  • Regents of the University of California first reported a position in Puma Biotechnology in Q1 2015 and held it in 1 quarter.
  • Regents of the University of California's Puma Biotechnology position peaked at $2.1M in Q1 2015.
  • 198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on Regents of the University of California's 13F filing for Q2 2015, filed 6 Aug 2015.